SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-22-017068
Filing Date
2022-05-02
Accepted
2022-05-02 16:25:25
Documents
6
Effectiveness Date
2022-05-02

Document Format Files

Seq Description Document Type Size
1 S-8 trvi-s8.htm S-8 95044
2 EX-5.1 trvi-ex51_15.htm EX-5.1 13387
3 EX-23.2 trvi-ex232_16.htm EX-23.2 2568
4 EX-FILING FEES trvi-exfilingfees_45.htm EX-FILING FEES 24959
5 GRAPHIC gu3atdjfhbwr000001.jpg GRAPHIC 13959
6 GRAPHIC gu3atdjfhbwr000002.jpg GRAPHIC 96093
  Complete submission text file 0001564590-22-017068.txt   288838
Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Filer) CIK: 0001563880 (see all company filings)

IRS No.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-264615 | Film No.: 22882346
SIC: 2834 Pharmaceutical Preparations